Context dependent roles for RB-E2F transcriptional regulation in tumor suppression
Related Experiment Video
Updated: Jan 30, 2026

Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome
Published on: June 15, 2016
Michael J Thwaites1,2, Matthew J Cecchini3, Daniel T Passos1,2
1London Regional Cancer Program, Lawson Health Research Institute, London, Ontario, Canada.
Abstract:
RB-E2F transcriptional control plays a key role in regulating the timing of cell cycle progression from G1 to S-phase in response to growth factor stimulation. Despite this role, it is genetically dispensable for cell cycle exit in primary fibroblasts in response to growth arrest signals. Mice engineered to be defective for RB-E2F transcriptional control at cell cycle genes were also found to live a full lifespan with no susceptibility to cancer. Based on this background we sought to probe the vulnerabilities of RB-E2F transcriptional control defects found in Rb1R461E,K542E mutant mice (Rb1G) through genetic crosses with other mouse strains. We generated Rb1G/G mice in combination with Trp53 and Cdkn1a deficiencies, as well as in combination with KrasG12D. The Rb1G mutation enhanced Trp53 cancer susceptibility, but had no effect in combination with Cdkn1a deficiency or KrasG12D. Collectively, this study indicates that compromised RB-E2F transcriptional control is not uniformly cancer enabling, but rather has potent oncogenic effects when combined with specific vulnerabilities.
Insights
Defects in RB-E2F transcriptional control are not always linked to cancer. However, when combined with specific genetic vulnerabilities, such as Trp53 deficiency, these RB-E2F defects can promote cancer development.
Area of Science:
- Molecular Biology
- Cancer Biology
- Genetics
Background:
- RB-E2F transcriptional control is crucial for G1 to S-phase cell cycle progression.
- This control is dispensable for cell cycle exit during growth arrest.
- Mice lacking RB-E2F control show normal lifespan and no cancer predisposition.
Purpose of the Study:
- To investigate the vulnerabilities associated with RB-E2F transcriptional control defects.
- To examine the oncogenic potential of RB-E2F defects in combination with other genetic mutations.
Main Methods:
- Generation of Rb1R461E,K542E mutant mice (Rb1G).
- Genetic crosses of Rb1G/G mice with Trp53, Cdkn1a deficient, and KrasG12D mutant mice.
- Assessment of cancer susceptibility and oncogenic effects.
Main Results:
- The Rb1G mutation exacerbated cancer susceptibility when combined with Trp53 deficiency.
- Rb1G mutation showed no effect in combination with Cdkn1a deficiency.
- Rb1G mutation had no effect in combination with KrasG12D mutation.
Conclusions:
- Compromised RB-E2F transcriptional control is not universally oncogenic.
- Specific genetic contexts, like Trp53 deficiency, reveal potent oncogenic effects of RB-E2F defects.
- This highlights context-dependent vulnerabilities in cancer development.
More Related Videos
Related Concept Videos
Negative Regulator Molecules
Master Transcription Regulators
Master Transcription Regulators
Cooperative Binding of Transcription Regulators
Cooperative Binding of Transcription Regulators
Transcriptional Regulation: Riboswitches

